EyePoint Pharmaceuticals Statistics
Total Valuation
EYPT has a market cap or net worth of $458.34 million. The enterprise value is $163.47 million.
| Market Cap | 458.34M |
| Enterprise Value | 163.47M |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, before market open.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
EYPT has 52.08 million shares outstanding. The number of shares has increased by 41.15% in one year.
| Shares Outstanding | 52.08M |
| Shares Change (YoY) | +41.15% |
| Shares Change (QoQ) | +25.37% |
| Owned by Insiders (%) | 1.44% |
| Owned by Institutions (%) | 111.26% |
| Float | 34.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.16 |
| Forward PS | 11.62 |
| PB Ratio | 1.83 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.08, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.08 |
| Quick Ratio | 4.83 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -180.22 |
Financial Efficiency
Return on equity (ROE) is -49.90% and return on invested capital (ROIC) is -34.11%.
| Return on Equity (ROE) | -49.90% |
| Return on Assets (ROA) | -30.90% |
| Return on Capital (ROIC) | -34.11% |
| Revenue Per Employee | $413,380 |
| Profits Per Employee | -$652,190 |
| Employee Count | 121 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.14 |
Taxes
In the past 12 months, EYPT has paid $83,000 in taxes.
| Income Tax | 83,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.48% in the last 52 weeks. The beta is 1.60, so EYPT's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | -26.48% |
| 50-Day Moving Average | 9.96 |
| 200-Day Moving Average | 16.07 |
| Relative Strength Index (RSI) | 42.62 |
| Average Volume (20 Days) | 995,078 |
Short Selling Information
The latest short interest is 9.63 million, so 18.49% of the outstanding shares have been sold short.
| Short Interest | 9.63M |
| Short Previous Month | 8.98M |
| Short % of Shares Out | 18.49% |
| Short % of Float | 28.08% |
| Short Ratio (days to cover) | 9.64 |
Income Statement
In the last 12 months, EYPT had revenue of $50.02 million and -$78.92 million in losses. Loss per share was -$1.81.
| Revenue | 50.02M |
| Gross Profit | 45.27M |
| Operating Income | -86.83M |
| Pretax Income | -78.83M |
| Net Income | -78.92M |
| EBITDA | -77.74M |
| EBIT | -78.40M |
| Loss Per Share | -$1.81 |
Balance Sheet
The company has $299.50 million in cash and $4.62 million in debt, giving a net cash position of $294.87 million or $5.66 per share.
| Cash & Cash Equivalents | 299.50M |
| Total Debt | 4.62M |
| Net Cash | 294.87M |
| Net Cash Per Share | $5.66 |
| Equity (Book Value) | 249.93M |
| Book Value Per Share | 4.80 |
| Working Capital | 255.13M |
Cash Flow
In the last 12 months, operating cash flow was -$12.46 million and capital expenditures -$4.19 million, giving a free cash flow of -$16.65 million.
| Operating Cash Flow | -12.46M |
| Capital Expenditures | -4.19M |
| Free Cash Flow | -16.65M |
| FCF Per Share | -$0.32 |
Margins
Gross margin is 90.50%, with operating and profit margins of -173.60% and -157.77%.
| Gross Margin | 90.50% |
| Operating Margin | -173.60% |
| Pretax Margin | -157.60% |
| Profit Margin | -157.77% |
| EBITDA Margin | -155.41% |
| EBIT Margin | -156.73% |
| FCF Margin | -33.30% |
Dividends & Yields
EYPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.15% |
| Shareholder Yield | -41.15% |
| Earnings Yield | -17.22% |
| FCF Yield | -3.63% |
Analyst Forecast
The average price target for EYPT is $32.80, which is 272.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.80 |
| Price Target Difference | 272.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 47.30% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 9, 2020. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
EYPT has an Altman Z-Score of 0.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.48 |
| Piotroski F-Score | 3 |